These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study. Fruehauf S; Veldwijk MR; Seeger T; Schubert M; Laufs S; Topaly J; Wuchter P; Dillmann F; Eckstein V; Wenz F; Goldschmidt H; Ho AD; Calandra G Cytotherapy; 2009; 11(8):992-1001. PubMed ID: 19929463 [TBL] [Abstract][Full Text] [Related]
25. Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantation. Flomenberg N; Comenzo RL; Badel K; Calandra G Biol Blood Marrow Transplant; 2010 May; 16(5):695-700. PubMed ID: 20067838 [TBL] [Abstract][Full Text] [Related]
26. Can every patient be mobilized? DiPersio JF Best Pract Res Clin Haematol; 2010 Dec; 23(4):519-23. PubMed ID: 21130416 [TBL] [Abstract][Full Text] [Related]
27. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472 [TBL] [Abstract][Full Text] [Related]
28. Hematopoietic Progenitor Cell Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma in Contemporary Era. Arora S; Majhail NS; Liu H Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):200-205. PubMed ID: 30679106 [TBL] [Abstract][Full Text] [Related]
30. AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice. Pulliam AC; Hobson MJ; Ciccone SL; Li Y; Chen S; Srour EF; Yang FC; Broxmeyer HE; Clapp DW Exp Hematol; 2008 Sep; 36(9):1084-90. PubMed ID: 18495331 [TBL] [Abstract][Full Text] [Related]
31. In and out of the niche: perspectives in mobilization of hematopoietic stem cells. Mohty M; Ho AD Exp Hematol; 2011 Jul; 39(7):723-9. PubMed ID: 21624427 [TBL] [Abstract][Full Text] [Related]
33. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Hess DA; Bonde J; Craft TP; Wirthlin L; Hohm S; Lahey R; Todt LM; Dipersio JF; Devine SM; Nolta JA Biol Blood Marrow Transplant; 2007 Apr; 13(4):398-411. PubMed ID: 17382247 [TBL] [Abstract][Full Text] [Related]
34. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Liles WC; Rodger E; Broxmeyer HE; Dehner C; Badel K; Calandra G; Christensen J; Wood B; Price TH; Dale DC Transfusion; 2005 Mar; 45(3):295-300. PubMed ID: 15752146 [TBL] [Abstract][Full Text] [Related]
35. New agents in HSC mobilization. Domingues MJ; Nilsson SK; Cao B Int J Hematol; 2017 Feb; 105(2):141-152. PubMed ID: 27905003 [TBL] [Abstract][Full Text] [Related]
36. Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience. Kosmas C; Athanasopoulos A; Dimitriadis G; Miltiadous C; Zilakos M; Lydakis D; Magiorkinis E; Gekas C; Daladimos T; Mylonakis N; Ziras N Anticancer Drugs; 2014 Aug; 25(7):841-7. PubMed ID: 24625457 [TBL] [Abstract][Full Text] [Related]